Delivery Order SPE2DB20D1100-SPE2DB25FD4M2

Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,409.58 firm fixed price delivery order is for the supply of Risperidone 3 mg tablets. The contract has an ultimate completion date of July 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 1 mg tablets. The contract has a ceiling value of $3,451.22 and a completion date of April 17, 2025. It is a firm fixed-price contract, and the order was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,384,072 units of Risperidone 1 mg tablets in 500-count packages. The firm-fixed-price delivery order has a ceiling value of $1,852.66 and a completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,859.42, is for the supply of Risperidone 1 mg tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,737.03 firm fixed-price contract is for the delivery of 4,560,317 units of the 0.5 mg Risperidone tablet, with a completion date of March 21, 2023. The award is not designated under a set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,907.00, is for the delivery of Risperidone 3 mg tablets, a medication used to treat certain mental health conditions. The contract has an ultimate completion date of November 15, 2023 and is a firm fixed-price contract type. This contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,400.27 firm fixed-price delivery order is for the supply of 60 count packages of 2 mg Risperidone tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024 with no set-aside designation, indicating open...
This federal contract award, valued at $2,121.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Risperidone 3 mg tablets, a medication used to treat mental health conditions. The contract has an ultimate completion date of November 14, 2022 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $2,452.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,566 units of Risperidone 1 mg tablets, a medication used for the treatment of mental health conditions. The contract has an ultimate completion date of March 14, 2025 and is structured as a firm fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Risperidone 3 mg tablets. The contract has a ceiling value of $1,013.91 and a performance period through May 21, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD4M2
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,565.04 contract is for the delivery of Risperidone 3 mg tablets to support federal medical supply requirements, with a completion date of July 16, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard, in support of military and veteran healthcare systems. The contract award described is not designated as a set-aside.

Generated 10/14/25, 10:50 AM